A review of the therapeutic agents used in the management of polycythaemia vera-Reference-Cited by-同舟云学术

A review of the therapeutic agents used in the management of polycythaemia vera

Published:2007 Issue:2 Volume:25 Page:58-65
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol. Oncol.

Author:

McMullin Mary Frances

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference72 articles.

1. CEREBRAL BLOOD-FLOW IN POLYCYTHqMIA

2. VASCULAR OCCLUSIVE EPISODES AND VENOUS HÆMATOCRIT IN PRIMARY PROLIFERATIVE POLYCYTHÆMLX

3. , , . Treatment of polycythaemia vera, a summary of clinical trends conducted by the polycythaemia vera sub-group. In: (eds). Treatment of polycythaemia vera, a summary of clinical trends conducted by the polycythaemia vera study group. W.B. Saunders: Philadelphia, 1995; 166–194.

4. The very-long-term course of polycythaemia: a complement to the previously published data of the Polycythaemia Vera Study Group

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simply red: A novel spectrophotometric erythroid proliferation assay as a tool for erythropoiesis and erythrotoxicity studies;Biotechnology Reports;2014-12

3. A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs;Annals of Hematology;2010-02-10

4. S?ndromes mieloproliferativos: concepto y etiopatogenia. Clasificaci?n. Cl?nica. Criterios diagn?sticos. Estrategias terap?uticas;Medicine - Programa de Formaci?n M?dica Continuada Acreditado;2008-11

5. Congenital and Acquired Polycythemias;Deutsches Ärzteblatt international;2008-01-25